Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
Int J Cancer. 2012 Sep 1;131(5):1187-96. doi: 10.1002/ijc.27327. Epub 2011 Dec 21.
Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Lane JA, Martin RM.
School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom. Becky.Gilbert at bristol.ac.uk
Epidemiological studies suggest that vitamin D protects against prostate cancer, although evidence is limited and inconsistent. We investigated associations of circulating total 25-hydroxyvitamin D OH)D) with prostate specific antigen-detected prostate cancer in a case-control study nested within the prostate testing for cancer and treatment (ProtecT) trial. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) quantifying the association between circulating total 25(OH)D and prostate cancer. In case-only analyses, we used unconditional logistic regression to quantify associations of total 25(OH)D with stage (advanced vs. localized) and Gleason grade (high-grade (?7) vs. low-grade (<7. Predetermined categories of total 25(OH)D were defined as: high: ?30 ng/mL; adequate: 20-<30 ng/mL; insufficient: 12-<20 ng/mL; deficient: <12 ng/mL. Fractional polynomials were used to investigate the existence of any U-shaped relationship.
We included 1,447 prostate cancer cases (153 advanced, 469 high-grade) and 1,449 healthy controls.
There was evidence that men deficient in vitamin D had a 2-fold increased risk of advanced versus localized cancer (OR for deficient vs. adequate total 25(OH)D=2.33, 95% CI: 1.26, 4.28) and high-grade versus low-grade cancer (OR for deficient vs. adequate total 25(OH)D=1.78, 95% CI: 1.15, 2.77).
There was no evidence of a linear association between total 25(OH)D and prostate cancer (p=0.44) or of an increased risk of prostate cancer with high and low vitamin D levels. Our study provides evidence that lower 25(OH)D concentrations were associated with more aggressive cancers (advanced versus localized cancers and high- versus low-Gleason grade), but there was no evidence of an association with overall prostate cancer risk.
Copyright © 2011 UICC.
PMID: 22033893
Download the PDF from VitaminDWiki
See also VitaminDWiki
- All items in category Prostate Cancer and vitamin D
103 items - Low risk Prostate Cancer decreased with 4,000 IU of vitamin D – July 2012
- Prostate cancer reduced in high vitamin D two studies – April 2012
- PhD Dissertation - Local production of active vitamin D inhibits Prostate Cancer – Oct 2012
See also web
- Vitamin D, Sunlight, and the Epidemiology of Prostate Cancer Schwartz GG. Oct 2012
Vitamin D and Calcium as well as UV continues to look promising
Advanced prostate cancer 2X more likely if low vitamin D – Sept 2012Printer Friendly Follow this page for updates6538 visitors, last modified 27 Jan, 2016, This page is in the following categories (# of items in each category)